SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,566,000 | +17.6% | 31,200 | -12.1% | 0.09% | -2.2% |
Q3 2019 | $3,032,000 | +125.9% | 35,500 | +83.0% | 0.09% | +89.4% |
Q2 2019 | $1,342,000 | -59.9% | 19,400 | -57.5% | 0.05% | -59.5% |
Q1 2019 | $3,347,000 | +129.2% | 45,696 | +61.9% | 0.12% | -23.2% |
Q2 2017 | $1,460,000 | -41.2% | 28,218 | -40.1% | 0.15% | -53.1% |
Q4 2016 | $2,484,000 | – | 47,077 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |